scholarly article | Q13442814 |
P50 | author | Ralph Weichselbaum | Q19668192 |
Everett E Vokes | Q73567428 | ||
Ravi Salgia | Q73567837 | ||
Tanguy Y Seiwert | Q89776148 | ||
Mark W. Lingen | Q113027272 | ||
Rifat Hasina | Q113027582 | ||
Rajani Kanteti | Q113027596 | ||
P2093 | author name string | Cleo E Rolle | |
Mosmi Surati | |||
Sapana Vora | |||
Yi-Hung Carol Tan | |||
George B Carey | |||
P2860 | cites work | Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b | Q27646953 |
Cancer statistics, 2014 | Q27861018 | ||
c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination | Q28203098 | ||
The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met | Q28207199 | ||
p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl | Q28280007 | ||
The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system | Q28634501 | ||
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. | Q30177048 | ||
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma | Q30494514 | ||
Platinum-based chemotherapy plus cetuximab in head and neck cancer | Q33381094 | ||
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival | Q33515519 | ||
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases | Q33528991 | ||
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer | Q33990915 | ||
Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation | Q34097397 | ||
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck | Q34533587 | ||
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients | Q35600799 | ||
The Cbl family proteins: ring leaders in regulation of cell signaling | Q36495318 | ||
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway | Q36565319 | ||
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy | Q36731520 | ||
The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein | Q36832426 | ||
Expression and mutational analysis of MET in human solid cancers | Q36975055 | ||
Head and neck cancer: changing epidemiology, diagnosis, and treatment | Q37125036 | ||
Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas | Q41117144 | ||
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy | Q41725449 | ||
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms | Q42795736 | ||
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head | Q56688854 | ||
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base | Q57949385 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mutational analysis | Q1955810 |
P304 | page(s) | 18726-18734 | |
P577 | publication date | 2016-05-26 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma | |
P478 | volume | 8 |
Q89739717 | Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset | cites work | P2860 |
Search more.